| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.00B | 32.98B | 32.52B | 31.55B | 27.95B | 25.13B |
| Gross Profit | 6.26B | 6.51B | 6.19B | 4.65B | 3.59B | 3.79B |
| EBITDA | 3.46B | 3.65B | 3.44B | 2.07B | 1.25B | 1.46B |
| Net Income | 2.13B | 2.77B | 2.14B | 1.48B | 498.00M | 609.00M |
Balance Sheet | ||||||
| Total Assets | 28.13B | 31.81B | 29.41B | 27.51B | 25.89B | 26.13B |
| Cash, Cash Equivalents and Short-Term Investments | 1.67B | 2.89B | 3.31B | 2.31B | 2.21B | 3.53B |
| Total Debt | 7.83B | 6.73B | 8.25B | 10.17B | 11.83B | 13.08B |
| Total Liabilities | 11.26B | 11.21B | 12.79B | 13.79B | 14.86B | 15.75B |
| Stockholders Equity | 16.87B | 20.60B | 16.62B | 13.71B | 11.03B | 10.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.81B | 3.15B | 1.83B | 150.00M | 591.00M |
| Operating Cash Flow | 0.00 | 2.66B | 3.70B | 2.11B | 447.00M | 1.08B |
| Investing Cash Flow | 0.00 | -1.13B | -520.00M | -227.00M | -374.00M | -711.00M |
| Financing Cash Flow | 0.00 | -1.93B | -2.17B | -1.79B | -1.40B | -1.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥50.36B | 9.98 | ― | 2.12% | 6.02% | 101.02% | |
71 Outperform | ¥12.22B | 6.44 | ― | 1.91% | 1.42% | 29.11% | |
69 Neutral | ¥31.64B | 10.29 | ― | 2.84% | 1.00% | 15.35% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥102.70B | -8.07 | ― | 3.97% | 0.74% | -35.11% |